Literature DB >> 17428287

Heart and lung transplantation in the United States, 1996-2005.

E R Garrity1, J Moore, M S Mulligan, T H Shearon, M J Zucker, S Murray.   

Abstract

This article examines the Organ Procurement and Transplantation Network/Scientific Registry of Transplant Recipients data on heart and lung transplantation in the United States from 1996 to 2005. The number of heart transplants performed and the size of the heart waiting list continued to drop, reaching 2126 and 1334, respectively, in 2005. Over the decade, post-transplant graft and patient survival improved, as did the chances for survival while on the heart waiting list. The number of deceased donor lung transplants increased by 78% since 1996, reaching 1407 in 2005 (up 22% from 2004). There were 3170 registrants awaiting lung transplantation at the end of 2005, down 18% from 2004. Death rates for both candidates and recipients have been dropping, as has the time spent waiting for a lung transplant. Other lung topics covered are living donation, recent surgical advances and changes in immunosuppression regimens. Heart-lung transplantation has declined to a small (33 procedures in 2005) but important need in the United States.

Entities:  

Mesh:

Year:  2007        PMID: 17428287     DOI: 10.1111/j.1600-6143.2007.01783.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

Review 1.  A review of the potential applications and controversies of non-invasive testing for biomarkers of aspiration in the lung transplant population.

Authors:  C S Davis; J Gagermeier; D Dilling; C Alex; E Lowery; E J Kovacs; R B Love; P M Fisichella
Journal:  Clin Transplant       Date:  2010-03-19       Impact factor: 2.863

2.  Detection of bronchial function of NHBD lung following one-h warm ischemia by organ bath model.

Authors:  Yang Yang; Song Zhao; Qiuming Liao; Jianjun Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

3.  A sphingosine 1-phosphate 1 receptor agonist modulates brain death-induced neurogenic pulmonary injury.

Authors:  Saad Sammani; Ki-Sung Park; Syed R Zaidi; Biji Mathew; Ting Wang; Yong Huang; Tong Zhou; Yves A Lussier; Aliya N Husain; Liliana Moreno-Vinasco; Wickii T Vigneswaran; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2011-05-26       Impact factor: 6.914

Review 4.  Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments.

Authors:  Luigi Santambrogio; Paolo Tarsia; Paolo Mendogni; Davide Tosi
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 5.  Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help?

Authors:  David Simpson; Samuel C Dudley
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

6.  Usefulness of immune monitoring in lung transplantation using adenosine triphosphate production in activated lymphocytes.

Authors:  Michael Y Shino; S Samuel Weigt; Rajan Saggar; David Elashoff; Ariss Derhovanessian; Aric L Gregson; Rajeev Saggar; Elaine F Reed; Bernard M Kubak; Joseph P Lynch; John A Belperio; Abbas Ardehali; David J Ross
Journal:  J Heart Lung Transplant       Date:  2012-09       Impact factor: 10.247

Review 7.  Preserving and evaluating hearts with ex vivo machine perfusion: an avenue to improve early graft performance and expand the donor pool.

Authors:  Michael J Collins; Sina L Moainie; Bartley P Griffith; Robert S Poston
Journal:  Eur J Cardiothorac Surg       Date:  2008-06-06       Impact factor: 4.191

8.  Lipopolysaccharide pre-conditioning is protective in lung ischemia-reperfusion injury.

Authors:  Heather E Merry; Patrick S Wolf; Elizabeth Fitzsullivan; John C Keech; Michael S Mulligan
Journal:  J Heart Lung Transplant       Date:  2009-12-31       Impact factor: 10.247

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.